2024 Annual Meeting | C46 - Child Neurology: Neuro-oncology
| 01:00 PM - 01:40 PM MDT | Speaker |
Pediatric CNS Tumor Review and Updates
Sonia Partap, MD, FÂé¶¹´«Ã½Ó³», Nicole Ullrich, MD, PhD, MMSci, FÂé¶¹´«Ã½Ó³» |
| 01:40 PM - 02:20 PM MDT | Speaker |
Molecular Therapies in Neurocutaneous Syndromes and Low-grade Glioma
Yasmin Khakoo, MD, FCNS, FAAP, FÂé¶¹´«Ã½Ó³» |
| 02:20 PM - 03:00 PM MDT | Speaker |
Neurologic Toxicity in Survivors of Childhood Brain Tumors
Nicole Ullrich, MD, PhD, MMSci, FÂé¶¹´«Ã½Ó³» |
| Sonia Partap, MD, FÂé¶¹´«Ã½Ó³» | The institution of Dr. Partap has received research support from NIH. |
| Nicole Ullrich, MD, PhD, MMSci, FÂé¶¹´«Ã½Ó³» | The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care. |
| Yasmin Khakoo, MD, FCNS, FAAP, FÂé¶¹´«Ã½Ó³» | Dr. Khakoo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Khakoo has a non-compensated relationship as a President with Child Neurology Society that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |